108
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

Differential use of the hematopoietic cell transplantation-comorbidity index among adult and pediatric transplant physicians

ORCID Icon, ORCID Icon, ORCID Icon, , , , , , , & show all
Pages 2507-2510 | Received 07 Feb 2022, Accepted 04 May 2022, Published online: 18 May 2022

References

  • Sorror ML, Maris MB, Storb R, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005;106(8):2912–2919.
  • Sorror ML, Logan BR, Zhu X, et al. Prospective validation of the predictive power of the hematopoietic cell transplantation comorbidity index: a center for international blood and marrow transplant research study. Biol Blood Marrow Transplant. 2015;21(8):1479–1487.
  • Thakar MS, Broglie L, Logan B, et al. The hematopoietic cell transplant comorbidity index predicts survival after allogeneic transplant for nonmalignant diseases. Blood. 2019;133(7):754–762.
  • Smith AR, Majhail NS, MacMillan ML, et al. Hematopoietic cell transplantation comorbidity index predicts transplantation outcomes in pediatric patients. Blood. 2011;117(9):2728–2734.
  • Friend BD, Tang K, Markovic D, et al. Identifying risk factors associated with worse outcomes in adolescents and young adults undergoing hematopoietic stem cell transplantation. Pediatr Blood Cancer. 2019;66(12):e27940.
  • Broglie L, Ruiz J, Jin Z, et al. Limitations of applying the hematopoietic cell transplantation comorbidity index in pediatric patients receiving allogeneic hematopoietic cell transplantation. Transplant Cell Ther. 2021;27(1):74.e1–74.e9.
  • Wood W, Deal A, Whitley J, et al. Usefulness of the hematopoietic cell transplantation-specific comorbidity index (HCT-CI) in predicting outcomes for adolescents and young adults with hematologic malignancies undergoing allogeneic stem cell transplant. Pediatr Blood Cancer. 2011;57(3):499–505.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.